Key Points
Ahead of the listing, the company's shares are commanding a premium of Rs 61 in the unlisted market...
Based on the current GMP, the company's shares are likely to get a premium of 14% on the listing..
However, it is important to note that grey market premiums are just an indicator of how the company's shares are stacked up in the unlisted market and are subject to change rapidly...
Innova Captab is an integrated pharmaceutical company in India with a presence across the pharmaceuticals value chain including research and development, manufacturing, drug distribution, and marketing and exports...
In FY22, among Indian formulation CDMO players considered in the CRISIL Report, it recorded the third highest operating revenue, the second highest operating profit margin, the third highest net profit margin and the second highest return on capital employed...
You might be interested in
Concord Biotech shares list at 21% premium over IPO price
18, Aug, 23Concord Biotech is a biotechnology company and a leading maker of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022. The company is backed by Rakesh Jhunjhunwala's Rare Enterprises and another leading investment firm Quadria Capital Fund. Ahead of the listing, the company's shares commanded a premium of Rs 120 in the unlisted market.
Innova Captab IPO: Know GMP, how to check share allotment, listing date and all other details
27, Dec, 23Innova Captab is an all-encompassing pharmaceutical company in India, engaged in different facets of the pharmaceutical value chain such as research a
Innova Captab share price jumps 20% after tepid listing. What should investors do?
29, Dec, 23The lackluster debut performance fell way short of expectations, which highlights the potential risks associated with the highly competitive market, regulatory environment, and currency fluctuations.
Will Senco Gold deliver listing gains for investors on Friday? Here's what GMP suggests
13, Jul, 23Senco Gold is likely to debut on the stock market at a premium of around 37%, with grey market premiums sitting at approximately INR115-120 ($1.54-$1.60) ahead of listing, according to industry sources. The INR405 crore ($54.2m) IPO was well subscribed, with the QIB-pool generating 180 times coverage.
Innova Captab IPO: December 26 is the last day to subscribe; Here are key risks to know
25, Dec, 23Innova Captab initial public offering opened for subscription on Thursday, December 21 and will close on December 26.
Bumper Debut! Netweb Technologies shares list at 89% premium over IPO price
27, Jul, 23The IPO of Netweb, a leading high-end computing solutions (HCS) provider with fully integrated design and manufacturing capabilities, was subscribed 90.36 times at close. The qualified institutional buyer portion was the most subscribed with a subscription of 228.91 times, followed by non-institutional investors with 81.81 times. The retail category was subscribed 19.15 times.
Solid Start! Ideaforge IPO fully subscribed within hours of opening on robust retail demand
26, Jun, 23The robust demand was driven by retail investors, whose category was subscribed 4.38 times. While the non-institutional portion was subscribed 1.03 times, there were no bids yet from qualified institutional buyers.
Azad Engineering shares to make D-Street debut on Thursday. Here’s what GMP signals
27, Dec, 23If the current trends are sustained, Azad Engineering's shares are expected to list at a premium of 53%. The issue was priced in the range of Rs 499-524.
Ideaforge IPO: GMP soars nearly 80% as issue gets fully subscribed. Here's what brokerages say
26, Jun, 23The NII part was subscribed 1.89 times so far, while there were no bids from qualified institutional buyers. According to market sources, the company's shares are commanding a premium of Rs 525-530 in the unlisted market, indicating big listing gains for investors if the trends sustain.
Valiant Laboratories shares to debut on Friday. What GMP signals ahead of listing
05, Oct, 23Considering the upper price band of Rs 140, the stock is likely to debut with a premium of 16%. The IPO was well-received by investors with a subscription rate of 29.76 times.